Volume 34
Issue 4, 2014
ISSX President’s Message By John O. Miners, ISSX President 2014 has been a good year for ISSX. The Society held two successful scientific meetings, our financial position is strong, and planning for future meetings and several new initiatives is well advanced. As I indicated in a previous issue of the Newsletter, the 5th Asia Pacific Meeting, which was held in Tianjin, China had 550 participants and approximately 300 poster presentations. The meeting was hosted by our affiliate partner, the Chinese Society for the Study of Xenobiotics (CSSX). The joint 19th North American ISSX / 29th JSSX Meeting, held from October 19–23 in San Francisco, was also an outstanding success. Like our previous joint meeting with JSSX in Maui in 2005, there were over 1,100 attendees and more than 600 abstracts. The standard of the scientific presentations and posters was excellent, and the meeting was well-supported by exhibitors. Drs. Tetsuya Terasaki and Eric Johnson, the meeting co-chairs, and their colleagues on the Meeting Organizing
Committee, are to be congratulated for their efforts on behalf of ISSX and JSSX and for delivering such a high quality conference. Given the success of our two previous joint meetings with JSSX, our two Societies have agreed to hold another joint meeting in 2020. Two meetings are scheduled for 2015. The 13th European ISSX Meeting will be held in Glasgow from June 22–25. The call for abstracts for this meeting is now open and the scientific program is available on the ISSX website. The 20th North American ISSX Meeting will be held in Orlando from October 18-22. Two scientific awards will be presented at each of these meetings. The ISSX Awards Program recognizes the scientific and service achievements of our members. Nominations are currently being accepted for awards that will be presented in Glasgow: the European New Investigator Award (in honor of Karl J. Netter) and the European Scientific Achievement Award. Members are urged to nominate colleagues who may
be eligible for these awards – details on the nomination process are available on the ISSX website. ISSX will sponsor the participation of four speakers to attend the Drug Metabolism and Pharmacokinetics Symposium at the National Institute of Pharmaceutical Education and Research (NIPER) to be held in Mohali, India in February 2015. Our formal participation in the NIPER Symposium follows negotiations initiated by past-President Bill Smith. ISSX involvement in India is consistent with key objectives of the Society’s Strategic Plan: increasing internationalization, expanding scientific outreach, and growing membership. Like many organizations, both for profit and non-profit, the Society’s financial position weakened with Continued on page 4
IN THIS ISSUE 1
ISSX President’s Message
North American ISSX / 3 19th 29th JSSX Meeting Review
2
Book Review: Statistical Methods for Evaluating Safety in Medical Product Development
7
Welcome New Members
the Date: 13th European 9 Save ISSX Meeting